Literature DB >> 4054200

Pharmacokinetics of theophylline and enprofylline in patients requiring a high or low dose of theophylline.

L C Laursen, N Johannesson, B Weeke.   

Abstract

In patients requiring a high or low dose of theophylline the pharmacokinetics of theophylline and enprofylline were studied. The low-dose group took an average daily dose of 8.91 mg/kg body wt. and the high-dose group 24.75 mg/kg body wt. The average half-life of theophylline in the former was 7.11 h and in the latter 4.72 h. The average clearances (CL) of theophylline were 2.83 and 4.58 l/h, respectively. The daily oral intake of theophylline was negatively correlated with the theophylline t1/2 (r = -0.63). While the t1/2 of enprofylline was similar in the two groups, CL and volume of distribution (Vc) were slightly (about 30%) but significantly higher in patients requiring a high dose of theophylline. CL of enprofylline did not correlate with CL of theophylline, nor was the Vc of the two drugs correlated. Interindividual variability in t1/2 and CL was considerably lower for enprofylline than for theophylline.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4054200     DOI: 10.1007/BF00547379

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  12 in total

1.  Pharmacokinetics of theophylline. Application to adjustment of the clinical dose of aminophylline.

Authors:  J W Jenne; M S Wyze; F S Rood; F M MacDonald
Journal:  Clin Pharmacol Ther       Date:  1972 May-Jun       Impact factor: 6.875

2.  Pharmacokinetic parameters: which are necessary to define a drug substance?

Authors:  L Z Benet
Journal:  Eur J Respir Dis Suppl       Date:  1984

3.  Continuous treatment of asthmatic patients with enprofylline and theophylline.

Authors:  L C Laursen; N Johannesson; B Weeke
Journal:  Eur J Respir Dis       Date:  1984-10

4.  Enprofylline kinetics in healthy subjects after single doses.

Authors:  O Borgå; K E Andersson; L E Edholm; P O Fagerström; E Lunell; C G Persson
Journal:  Clin Pharmacol Ther       Date:  1983-12       Impact factor: 6.875

5.  Differentiation between bronchodilation and universal adenosine antagonism among xanthine derivatives.

Authors:  C G Persson; J A Karlsson; I Erjefält
Journal:  Life Sci       Date:  1982-06-21       Impact factor: 5.037

6.  Maximally effective plasma concentrations of enprofylline and theophylline during constant infusion.

Authors:  L C Laursen; N Johannesson; I Søndergaard; B Weeke
Journal:  Br J Clin Pharmacol       Date:  1984-10       Impact factor: 4.335

Review 7.  Specific methods for theophylline assay in biological samples.

Authors:  L E Edholm
Journal:  Eur J Respir Dis Suppl       Date:  1980

8.  Furosemide kinetics and dynamics after kidney transplant.

Authors:  D E Smith; J G Gambertoglio; F Vincenti; L Z Benet
Journal:  Clin Pharmacol Ther       Date:  1981-07       Impact factor: 6.875

9.  Intravenous administration of enprofylline to asthmatic patients.

Authors:  L C Laursen; N Johannesson; P O Fagerström; B Weeke
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

10.  Enprofylline--effects of a new bronchodilating xanthine derivative in asthmatic patients.

Authors:  L C Laursen; N Johannesson; A Dirksen; R Djurup; E P Munch; E Taudorf; B Weeke
Journal:  Allergy       Date:  1983-01       Impact factor: 13.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.